XTL Biopharmaceuticals Ltd.
Records under this name other than patents XTL Biopharmaceuticals Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to XTL Biopharmaceuticals Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,785,595 | Stabilized anti-hepatitis B (HBV) antibody formulations Formerly held Lapsed on the fee record Ended Aug 31, 2018 · USPTO record | Lapsed on the fee record | Ended Aug 31, 2018 | USPTO record |
| US RE39,586 | Human Monoclonal Antibody Against Hepatitis B Virus Surface Antigen (HBVSAG) Formerly held Term ended Term ended Jun 10, 2017 · Low confidence | Term ended | Term ended Jun 10, 2017 | Low confidence |
| US RE40,831 | Human Monoclonal Antibodies to the Hepatitis B Surface Antigen Formerly held Term ended Term ended Jun 10, 2017 · Low confidence | Term ended | Term ended Jun 10, 2017 | Low confidence |
| US 6,855,822 | Benzo[b]furan dimers Lapsed on the fee record Ended Feb 15, 2017 · USPTO record | Lapsed on the fee record | Ended Feb 15, 2017 | USPTO record |
| US 8,329,703 | Pyrazole compounds Lapsed on the fee record Ended Dec 11, 2016 · USPTO record | Lapsed on the fee record | Ended Dec 11, 2016 | USPTO record |
| US 8,263,078 | Antibodies Against Flagellin and Uses Thereof Formerly held Lapsed on the fee record Ended Sep 11, 2016 · High confidence | Lapsed on the fee record | Ended Sep 11, 2016 | High confidence |
| US 8,143,276 | 4-thio substituted quinoline and naphthyridine compounds Lapsed on the fee record Ended Mar 27, 2016 · USPTO record | Lapsed on the fee record | Ended Mar 27, 2016 | USPTO record |
| US 6,703,514 | 4-thio coumarins Formerly held Lapsed on the fee record Ended Mar 9, 2016 · USPTO record | Lapsed on the fee record | Ended Mar 9, 2016 | USPTO record |
| US 8,048,889 | 3,4-disubstituted coumarin and quinolone compounds Lapsed on the fee record Ended Nov 1, 2015 · USPTO record | Lapsed on the fee record | Ended Nov 1, 2015 | USPTO record |
| US 7,994,360 | Benzofuran compounds Lapsed on the fee record Ended Aug 9, 2015 · USPTO record | Lapsed on the fee record | Ended Aug 9, 2015 | USPTO record |